Altered TCR signaling in anergy
Altered TCR signaling in anergy
批准号:
10750486
负责人:
Virginia Smith Shapiro
金额:
$24.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-06 至 2025-06-30
关键词:
AccelerationAutoantigensAutoimmune DiseasesAutoimmunityBiochemical PathwayBone MarrowCD28 geneCD4 Positive T LymphocytesCellsChimera organismDefectDevelopmentDiabetes MellitusFrequenciesGenerationsGuanosine TriphosphateHydrolysisImmune responseIn VitroInterleukin-2Knockout MiceMaintenanceMemoryMitogen-Activated Protein KinasesModelingMolecularMusPIK3CG genePathway interactionsPeptidesPeripheralProductionProliferatingRegulationRepressionRoleSignal PathwaySignal TransductionStimulusStructureT cell anergyT cell regulationT-Cell ActivationT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsTamoxifenTransgenic MiceTransgenic OrganismsUp-RegulationWorkacute myeloid leukemia 1 proteinanergyautoreactive T cellconditional knockoutin vivoin vivo Modelinsightnovelnovel therapeuticsoverexpressionperipheral tolerancepreventprogramsras GTPase-Activating Proteinstranscription factortranscriptome sequencing
中文摘要
摘要
T细胞无能是一种对自身抗原无反应的细胞固有程序,是一种重要的
周长公差的组成部分。因为无能的诱导和维持是预防
耐受性的崩溃和自身免疫的启动,重要的是要了解其机制和
调节无能的分子。最初,T细胞无能是在缺乏TCR刺激的情况下诱导的
在体外,共刺激和各种刺激已经被用来诱导无能。这项早期工作证明了
激活RAS/MAPK通路在TCR/CD28刺激T细胞中的重要作用
活化、IL-2的产生和增殖。然而,RAS/MAP的作用机制尚不清楚
在无能T细胞中,激酶途径被下调。近年来,WT小鼠内源性无能T细胞
以CD73和FR4的高表达为特征。我们发现这些
WT小鼠体内天然无能FR4+CD73+CD4+T细胞表达较低水平的RUNX1蛋白
与其他CD4+T细胞亚群比较。条件性TCR/CD28诱导的CD4+T细胞活化
与WT的激活相比,RUNX1的缺失导致IL-2的表达降低和增殖减少
CD4+T细胞。此外,自然无能的FR4+CD73+CD4+T细胞在CD4-T细胞中的比例较高。
Cre RUNX1条件性基因敲除(CKO)小鼠或他莫昔芬治疗的ER-cre RUNX1 CKO混合骨小鼠
骨髓嵌合体。因此,成熟的CD4+T细胞中RUNX1的缺失使其易于T细胞的发育
细胞无能。了解RUNX1缺陷T细胞低应答的机制(S)
在TCR/CD28刺激下,对WT和RUNX1缺陷的CD4+T细胞进行RNAseq分析。
RUNX1缺陷的CD4+T细胞上调了Dab2IP的表达,Dab2IP是一种适配器分子,已在
非造血细胞可能是RAS信号的负调节因子。Dab2IP包含RAS-GAP域,
这导致了RAS的失活,加速了GTP对GDP的水解。以确定是否
Dab2IP表达增加可抑制T细胞活化,促进无能诱导,我们产生了
新型cre依赖、dox可调节的dab2ip转基因小鼠。我们的初步结果表明,
以RUNX1为条件缺失的CD4+T细胞,Dab2IP TG的CD4+T细胞出现频率升高
自然无能的FR4+CD73+CD4+T细胞在他们的记忆细胞池中。我们的假设是增加了
Dab2IP的表达干扰了正常的TCR/CD28信号,阻止了T细胞的激活
使T细胞容易发展为无能。
英文摘要
Abstract
T cell anergy is a cell-intrinsic program of non-responsiveness to self-antigens, and is an important
component of peripheral tolerance. As the induction and maintenance of anergy is critical to preventing
breakdown of tolerance and initiation of autoimmunity, it is important to understand the mechanisms and
molecules that regulate anergy. Initially, T cell anergy was induced by TCR stimulation in the absence of
costimulation and a variety of stimuli have been used in vitro to induce anergy. This early work demonstrated
the critical importance of activation of the Ras/Map kinase pathway upon TCR/CD28 stimulation for T cell
activation, IL-2 production and proliferation. However, the mechanism is not clear as to how the Ras/Map
kinase pathway is downregulated in anergic T cells. Recently, endogenously anergic T cells in WT mice
have been identified and are characterized by high expression of CD73 and FR4. We have found that these
naturally anergic FR4+CD73+ CD4+ T cells in vivo from WT mice express lower levels of Runx1 protein as
compared to other CD4+ T cell subsets. TCR/CD28-induced activation of CD4+ T cells with conditional
deletion of Runx1 resulted in lower IL-2 expression and reduced proliferation as compared to activation of WT
CD4+ T cells. In addition, there was a higher frequency of naturally anergic FR4+CD73+ CD4+ T cells in CD4-
cre Runx1 conditional knockout (cKO) mice or tamoxifen-treated ER-cre Runx1 cKO mice in mixed bone
marrow chimeras. Thus, deletion of Runx1 in mature CD4+ T cells predisposes them to the development of T
cell anergy. To understand the mechanism(s) responsible for hypo-responsiveness of Runx1-deficient T cells
upon TCR/CD28 stimulation, RNAseq analysis was performed on WT and Runx1-deficient CD4+ T cells.
Runx1-deficient CD4+ T cells upregulated expression of Dab2IP, an adaptor molecule that has been shown in
non-hematopoietic cells to be a negative regulator of Ras signaling. Dab2IP contains a Ras-GAP domain,
which leads to the inactivation of Ras through accelerating hydrolysis of GTP to GDP. To determine whether
increased Dab2IP expression could inhibit T cell activation and promote anergy induction, we generated a
novel cre-dependent, dox-regulatable Dab2IP transgenic mouse. Our initial results demonstrate that similar
to CD4+ T cells conditionally deleted for Runx1, Dab2IP Tg CD4+ T cells have increased frequencies of
naturally anergic FR4+CD73+ CD4+ T cells in their memory cell pool. Our hypothesis is that increased
expression of Dab2IP interferes with normal TCR/CD28 signaling, preventing T cell activation, and
predisposing T cells to the development of anergy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Immunology
-
批准号:10493678
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2022
-
负责人:Virginia Smith Shapiro
-
依托单位:
Training Program in Immunology
-
批准号:10650170
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2022
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of B cell development by ABCB7
-
批准号:10374116
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2021
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10455700
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10225415
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of gene expression by HDAC3
-
批准号:10667604
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10529298
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10308083
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:9913027
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
ST8Sia6 expression on tumors inhibits the immune response
-
批准号:10054986
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2019
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell development by HDAC3
-
批准号:9543129
-
项目类别:
-
资助金额:$60.29万
-
财政年份:2017
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8823656
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8531478
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:8666663
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of hematopoietic stem cell maintenance and survival by NKAP
-
批准号:9040250
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2013
-
负责人:Virginia Smith Shapiro
-
依托单位:
The Role for NKAP in iNKT cell development
-
批准号:8316095
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2011
-
负责人:Virginia Smith Shapiro
-
依托单位:
The Role for NKAP in iNKT cell development
-
批准号:8087797
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2011
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell development and maturation by NKAP
-
批准号:8011439
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2010
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell development and maturation by NKAP
-
批准号:8415926
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2010
-
负责人:Virginia Smith Shapiro
-
依托单位:
Regulation of T cell maturation
-
批准号:9190269
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2010
-
负责人:Virginia Smith Shapiro
-
依托单位:
海外基金